Physician profile
Leticia Tornes
NPI 1922201623
$10,821.00
in general payments reported to CMS, 2019-2025
17 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,782 · 2020: $443 · 2021: $2,056 · 2022: $189 · 2023: $26.21 · 2024: $168 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $7,622.54 | 2019-2025 | Tysabri |
| Genentech, INC. | $1,782.67 | 2019-2021 | |
| Emd Serono, INC. | $392.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $293.65 | 2019-2024 | |
| Tg Therapeutics, INC. | $196.62 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $176.65 | 2019-2022 | |
| Banner Life Sciences, LLC | $91.42 | 2021-2022 | |
| Ucb, INC. | $71.13 | 2019-2021 | |
| Osprey Medical INC | $47.36 | 2021 | |
| Celgene Corporation | $30.81 | 2021 | |
| Greenwich Biosciences, INC. | $23.01 | 2019 | |
| Livanova USA, INC. | $22.93 | 2019 | |
| Abbvie INC. | $22.46 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.45 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.52 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.21 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leticia Tornes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.